CDK4: A Master Regulator of the Cell Cycle and Its Role in Cancer
Channel: Genes and Cancer
Date: 2022-09-08

Genes & Cancer published this review in Volume 13, entitled, "CDK4: a master regulator of the cell cycle and its role in cancer" by researchers from the Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, Levy Place, NY; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, Levy Place, NY; Department of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, Levy Place, NY; Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, Levy Place, NY.
#openaccess #cancer #cellcycle #peerreview #oncology 

DOI - https://doi.org/10.18632/genesandcancer.221
Correspondence to - E. Premkumar Reddy - ep.reddy@mssm.edu

Abstract

The cell cycle is regulated in part by cyclins and their associated serine/threonine cyclin-dependent kinases, or CDKs. CDK4, in conjunction with the D-type cyclins, mediates progression through the G1 phase when the cell prepares to initiate DNA synthesis. Although Cdk4-null mutant mice are viable and cell proliferation is not significantly affected in vitro due to compensatory roles played by other CDKs, this gene plays a key role in mammalian development and cancer. This review discusses the role that CDK4 plays in cell cycle control, normal development and tumorigenesis as well as the current status and utility of approved small molecule CDK4/6 inhibitors that are currently being used as cancer therapeutics.

Keywords - open access, cancer research, research, CDK4/6, cancer, cell cycle, targeted therapy; checkpoint inhibitor

About Genes & Cancer

Genes & Cancer covers all aspects of the structure and function of oncogenes, growth suppressor and apoptotic genes.

To learn more about Genes & Cancer, please visit https://www.genesandcancer.com/ and connect with us:

Facebook - https://www.facebook.com/GenesandCancer/
Twitter - https://twitter.com/GenesCancerJrnl
YouTube - https://www.youtube.com/channel/UCvlxdOvQQymzBWWbxAYyrRw
LinkedIn - https://www.linkedin.com/company/genes-&-cancer

Media Contact
MEDIA@IMPACTJOURNALS.COM
18009220957